Presentation is loading. Please wait.

Presentation is loading. Please wait.

From: The evolution and pathology of frontotemporal dementia

Published byEugenia Richards Modified over 6 years ago

Similar presentations

Presentation on theme: "From: The evolution and pathology of frontotemporal dementia"— Presentation transcript:

1 From: The evolution and pathology of frontotemporal dementia
Fig. 1 Survival curves according to underlying tau-positive and tau-negative pathologies. The log rank test found no significant difference between the pathology groups. From: The evolution and pathology of frontotemporal dementia Brain. 2005;128(9): doi: /brain/awh598 Brain | © The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please

2 From: The evolution and pathology of frontotemporal dementia
Fig. 2 The frequency of each pathology according to the first clinical syndrome. From: The evolution and pathology of frontotemporal dementia Brain. 2005;128(9): doi: /brain/awh598 Brain | © The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please

3 From: The evolution and pathology of frontotemporal dementia
Fig. 3 The evolution of clinical syndromes and final pathology in cases beginning with FTD. The average intervals (and SDs) between syndromes are expressed in years. From: The evolution and pathology of frontotemporal dementia Brain. 2005;128(9): doi: /brain/awh598 Brain | © The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please

4 From: The evolution and pathology of frontotemporal dementia
Fig. 4 The evolution of clinical syndromes and final pathology in cases beginning with PPA. From: The evolution and pathology of frontotemporal dementia Brain. 2005;128(9): doi: /brain/awh598 Brain | © The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please

5 From: The evolution and pathology of frontotemporal dementia
Fig. 5 The evolution of clinical syndromes and final pathology in cases beginning with a movement disorder. From: The evolution and pathology of frontotemporal dementia Brain. 2005;128(9): doi: /brain/awh598 Brain | © The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please

6 From: The evolution and pathology of frontotemporal dementia
Fig. 6 The frequency of clinical syndromes at each stage according to tau positive and negative histologies. From: The evolution and pathology of frontotemporal dementia Brain. 2005;128(9): doi: /brain/awh598 Brain | © The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please

7 From: The evolution and pathology of frontotemporal dementia
Fig. 7 Survival curves from symptom onset according to first clinical syndrome. The Log rank test found no significant differences between the clinical groups. From: The evolution and pathology of frontotemporal dementia Brain. 2005;128(9): doi: /brain/awh598 Brain | © The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please

Download ppt "From: The evolution and pathology of frontotemporal dementia"

Similar presentations

Osteoporosis therapy: an example of putting evidence- based medicine into clinical practice by D.J. Hosking, P. Geusens, and R. Rizzoli QJM Volume 98(6):403-413.

Osteoporosis therapy: an example of putting evidence- based medicine into clinical practice by D.J. Hosking, P. Geusens, and R. Rizzoli QJM Volume 98(6):
Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11):779-788 October 17, 2005 © The Author 2005. Published by Oxford University.

Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11): October 17, 2005 © The Author Published by Oxford University.
Disorders of cognitive and affective development in cerebellar malformations by Alessandro Tavano, Rita Grasso, Chiara Gagliardi, Fabio Triulzi, Nereo.

Disorders of cognitive and affective development in cerebellar malformations by Alessandro Tavano, Rita Grasso, Chiara Gagliardi, Fabio Triulzi, Nereo.
Fig. 1. Flow diagram of study participants and outcomes.

Fig. 1. Flow diagram of study participants and outcomes.
From: An open day in the metric space

From: An open day in the metric space
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
From: Global Banking: Recent Developments and Insights from Research*

From: Global Banking: Recent Developments and Insights from Research*
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Fig. 1 Mosaic display of PCEEC texts split according to time period, length of text, and gender of letter writer From: Variation in noun and pronoun frequencies.

Fig. 1 Mosaic display of PCEEC texts split according to time period, length of text, and gender of letter writer From: Variation in noun and pronoun frequencies.
Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.

Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.
From: Political Leadership and Power Redistribution

From: Political Leadership and Power Redistribution
Figure 1. The Modified Dual Pathway Model.

Figure 1. The Modified Dual Pathway Model.
Figure 1 Decrease in neuronal activity during n-back task in real tDCS as compared to sham stimulation. (A) Main effects of group (sham > real) based on.

Figure 1 Decrease in neuronal activity during n-back task in real tDCS as compared to sham stimulation. (A) Main effects of group (sham > real) based on.
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
Figure 6 Case 6: (A) MRA showed occlusion of the left internal carotid artery. (B) MRI 4 days before cell injection and (C) 7 days after cell injection.

Figure 6 Case 6: (A) MRA showed occlusion of the left internal carotid artery. (B) MRI 4 days before cell injection and (C) 7 days after cell injection.
Fig. 1 Flow chart of study selection

Fig. 1 Flow chart of study selection
Fig. 1. Subdomains contributing to effort-based decision making

Fig. 1. Subdomains contributing to effort-based decision making
Figure 1 Individual Lifted from Group Photograph

Figure 1 Individual Lifted from Group Photograph
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.
Fig. 1. Geographic locations of Shenzhen and Dongguan

Fig. 1. Geographic locations of Shenzhen and Dongguan

Similar presentations

Ads by Google